Loading...
Loading...
India's vildagliptin imports from TURKEY total $2110.6B across 235 shipments from 2 foreign suppliers. NOVARTIS PHARMA AG leads with $2110.6B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include NOVARTIS HEALTHCARE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for vildagliptin — a concentrated sourcing relationship with select suppliers from TURKEY.

NOVARTIS PHARMA AG is the leading Vildagliptin supplier from TURKEY to India, with import value of $2110.6B across 232 shipments. The top 5 suppliers — NOVARTIS PHARMA AG, M/S. NOVARTIS PHARMA AG — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVARTIS PHARMA AG | $2110.6B | 232 | 100.0% |
| 2 | M/S. NOVARTIS PHARMA AG | $7.0K | 3 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NOVARTIS HEALTHCARE PRIVATE LIMITED | $2110.6B | 235 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Vildagliptin suppliers from TURKEY to India include NOVARTIS PHARMA AG, M/S. NOVARTIS PHARMA AG. The leading supplier is NOVARTIS PHARMA AG with import value of $2110.6B USD across 232 shipments. India imported Vildagliptin worth $2110.6B USD from TURKEY in total across 235 shipments.
India imported Vildagliptin worth $2110.6B USD from TURKEY across 235 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Vildagliptin sourced from TURKEY include NOVARTIS HEALTHCARE PRIVATE LIMITED. The largest buyer is NOVARTIS HEALTHCARE PRIVATE LIMITED with $2110.6B in imports across 235 shipments.
The total value of Vildagliptin imports from TURKEY to India is $2110.6B USD, across 235 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
235 Verified Shipments
2 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists